Neuphoria Therapeutics's total assets for Q1 2025 were AU$22.92M, a decrease of -17.11% from the previous quarter. NEUP total liabilities were AU$5.85M for the fiscal quarter, a -42.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.